DE69832276D1 - Medikamentvorstufen der ribonukleotidreduktase-inhibitoren 3-ap und 3-amp - Google Patents
Medikamentvorstufen der ribonukleotidreduktase-inhibitoren 3-ap und 3-ampInfo
- Publication number
- DE69832276D1 DE69832276D1 DE69832276T DE69832276T DE69832276D1 DE 69832276 D1 DE69832276 D1 DE 69832276D1 DE 69832276 T DE69832276 T DE 69832276T DE 69832276 T DE69832276 T DE 69832276T DE 69832276 D1 DE69832276 D1 DE 69832276D1
- Authority
- DE
- Germany
- Prior art keywords
- benzyl
- ortho
- substituted
- reductase inhibitors
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- XMYKNCNAZKMVQN-NYYWCZLTSA-N [(e)-(3-aminopyridin-2-yl)methylideneamino]thiourea Chemical compound NC(=S)N\N=C\C1=NC=CC=C1N XMYKNCNAZKMVQN-NYYWCZLTSA-N 0.000 title abstract 3
- 229960005526 triapine Drugs 0.000 title abstract 3
- 229940127395 Ribonucleotide Reductase Inhibitors Drugs 0.000 title 1
- 238000009509 drug development Methods 0.000 title 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 4
- FYAKAEANAJIHHV-UUILKARUSA-N [(e)-(3-amino-4-methylpyridin-2-yl)methylideneamino]thiourea Chemical compound CC1=CC=NC(\C=N\NC(N)=S)=C1N FYAKAEANAJIHHV-UUILKARUSA-N 0.000 abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 102000028649 Ribonucleoside-diphosphate reductase Human genes 0.000 abstract 1
- 108010038105 Ribonucleoside-diphosphate reductase Proteins 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- -1 and R7 is H Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000006501 nitrophenyl group Chemical group 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US856568 | 1997-05-15 | ||
| US08/856,568 US5767134A (en) | 1997-05-15 | 1997-05-15 | Prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-AMP |
| PCT/US1998/009750 WO1998051669A1 (en) | 1997-05-15 | 1998-05-14 | Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69832276D1 true DE69832276D1 (de) | 2005-12-15 |
| DE69832276T2 DE69832276T2 (de) | 2006-08-03 |
Family
ID=25323971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69832276T Expired - Fee Related DE69832276T2 (de) | 1997-05-15 | 1998-05-14 | Medikamentvorstufen der ribonukleotidreduktase-inhibitoren 3-ap und 3-amp |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5767134A (de) |
| EP (1) | EP0988285B1 (de) |
| JP (1) | JP2001526664A (de) |
| KR (1) | KR20010012606A (de) |
| CN (2) | CN1256687A (de) |
| AT (1) | ATE309217T1 (de) |
| AU (1) | AU727848B2 (de) |
| BR (1) | BR9809633A (de) |
| CA (1) | CA2290617C (de) |
| DE (1) | DE69832276T2 (de) |
| RU (1) | RU2199531C2 (de) |
| WO (1) | WO1998051669A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000017225A2 (en) * | 1998-09-24 | 2000-03-30 | The Trustees Of Columbia University In The City Of New York | A small protein that interacts with a ribonucleotide reductase subunit and uses thereof |
| JP2002537262A (ja) * | 1999-02-18 | 2002-11-05 | オキシジェン，インコーポレイティド | 血管破壊のターゲッティングに使用するための組成物および方法 |
| JP4162994B2 (ja) * | 2000-10-13 | 2008-10-08 | ヴァイオン ファーマシューティカルズ， インコーポレイテッド | 諸疾患状態の処置のための薬物に使用する化合物とその製造方法 |
| WO2002085358A2 (en) * | 2001-04-20 | 2002-10-31 | Vion Pharmaceuticals, Inc. | Antiviral agents and methods of treating viral infections |
| US6855695B2 (en) * | 2003-06-13 | 2005-02-15 | Vion Pharmaceuticals, Inc. | Water-soluble SHPs as novel alkylating agents |
| CA2548491A1 (en) * | 2003-12-08 | 2005-06-23 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Synergistic anti-cancer compositions |
| CN101014353A (zh) * | 2004-03-26 | 2007-08-08 | 维奥恩药品公司 | 包含CloretazineTM的治疗组合物 |
| AU2005247319B2 (en) * | 2004-04-28 | 2011-12-01 | Molecules For Health, Inc. | Methods for treating or preventing restenosis and other vascular proliferative disorders |
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| AR054181A1 (es) | 2004-08-26 | 2007-06-06 | Nicholas Piramal India Ltd | Prodrogas que contienen enlaces bio-divisibles. composiiciones farmaceuticas |
| US7405317B2 (en) * | 2004-09-21 | 2008-07-29 | Vion Pharmaceuticals Inc. | Phosphate-bearing prodrugs of sulfonyl hydrazines as hypoxia-selective antineoplastic agents |
| US20090298891A1 (en) * | 2005-09-16 | 2009-12-03 | Government Of The Us, As Represented By The Secretady Of Health And Human Services | Methods of Treating or Preventing Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents |
| US9526707B2 (en) * | 2007-08-13 | 2016-12-27 | Howard L. Elford | Methods for treating or preventing neuroinflammation or autoimmune diseases |
| MD3995C2 (ro) * | 2009-05-11 | 2010-07-31 | Государственный Университет Молд0 | Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
| MD4126C1 (ro) * | 2010-11-15 | 2012-04-30 | Государственный Университет Молд0 | N,N'-[4,4'-(perfluoro-1,4-fenilendioxi)-bis(4,1-fenilen)]-bis[2-(piridin-2-ilmetilen)hidrazincarbotioamidă] şi utilizarea ei în calitate de inhibitor al proliferării celulelor LNCaP ale cancerului prostatei |
| TW201242953A (en) * | 2011-03-25 | 2012-11-01 | Bristol Myers Squibb Co | Imidazole prodrug LXR modulators |
| US20140271812A1 (en) | 2013-03-14 | 2014-09-18 | Panacea Pharmaceuticals | Treatment for chemotherapy-induced cognitive impairment |
| US20140287021A1 (en) | 2013-03-21 | 2014-09-25 | Panacea Pharmaceuticals | Treatment of chemotherapy-induced peripheral neuropathy |
| GB2589912A (en) * | 2019-12-12 | 2021-06-16 | Chemestmed Ltd | Method of suppressing cancer by RNA m6A methyltransferase mettl16 inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447427A (en) * | 1979-01-04 | 1984-05-08 | The United States Of America As Represented By The Secretary Of The Army | Method for treating bacterial infections with 2-acetyl- and 2-propionylpyridine thiosemicarbazones |
| US4385055A (en) * | 1979-01-04 | 1983-05-24 | The United States Of America As Represented By The Secretary Of The Army | 2-Acetyl-and 2-propionylpyridine thiosemicarbazones as antimalarials |
| US4696938A (en) * | 1986-04-25 | 1987-09-29 | Rohm And Haas Company | Insecticidal 6-aryl-pyridine thiosemicarbazones |
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
-
1997
- 1997-05-15 US US08/856,568 patent/US5767134A/en not_active Expired - Lifetime
-
1998
- 1998-05-14 AU AU74840/98A patent/AU727848B2/en not_active Ceased
- 1998-05-14 AT AT98922247T patent/ATE309217T1/de not_active IP Right Cessation
- 1998-05-14 CN CN98805148A patent/CN1256687A/zh active Pending
- 1998-05-14 EP EP98922247A patent/EP0988285B1/de not_active Expired - Lifetime
- 1998-05-14 CA CA002290617A patent/CA2290617C/en not_active Expired - Fee Related
- 1998-05-14 DE DE69832276T patent/DE69832276T2/de not_active Expired - Fee Related
- 1998-05-14 CN CN200810095427.9A patent/CN101302192B/zh not_active Expired - Lifetime
- 1998-05-14 KR KR1019997010565A patent/KR20010012606A/ko not_active Application Discontinuation
- 1998-05-14 JP JP54948498A patent/JP2001526664A/ja not_active Ceased
- 1998-05-14 RU RU99127343/04A patent/RU2199531C2/ru not_active IP Right Cessation
- 1998-05-14 WO PCT/US1998/009750 patent/WO1998051669A1/en active IP Right Grant
- 1998-05-14 BR BR9809633-8A patent/BR9809633A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010012606A (ko) | 2001-02-15 |
| EP0988285A4 (de) | 2000-08-16 |
| AU7484098A (en) | 1998-12-08 |
| JP2001526664A (ja) | 2001-12-18 |
| EP0988285A1 (de) | 2000-03-29 |
| CN101302192A (zh) | 2008-11-12 |
| BR9809633A (pt) | 2000-07-11 |
| AU727848B2 (en) | 2001-01-04 |
| CN1256687A (zh) | 2000-06-14 |
| RU2199531C2 (ru) | 2003-02-27 |
| ATE309217T1 (de) | 2005-11-15 |
| CA2290617C (en) | 2008-08-05 |
| EP0988285B1 (de) | 2005-11-09 |
| US5767134A (en) | 1998-06-16 |
| CA2290617A1 (en) | 1998-11-19 |
| DE69832276T2 (de) | 2006-08-03 |
| CN101302192B (zh) | 2014-01-22 |
| WO1998051669A1 (en) | 1998-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69832276D1 (de) | Medikamentvorstufen der ribonukleotidreduktase-inhibitoren 3-ap und 3-amp | |
| KR970707069A (ko) | 매트릭스 금속프로테아제 억제제로서 치환된 4-비아릴부티르산 또는 5-비아릴펜탄산 및 그의 유도체(substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metallorotease inhibitors) | |
| GR3032311T3 (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
| SE9203825D0 (sv) | Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them | |
| MX9200240A (es) | Derivados de 1-2[amino-3,4-dioxo-1-ciclobuten-1il]amino]alquil]-acido, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| ES2076935T3 (es) | Compuesto de pirazolopiridina y procedimientos para su preparacion. | |
| ES2141137T3 (es) | Agentes terapeuticos para la enfermedad de parkinson. | |
| NO963370D0 (no) | Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
| MY123908A (en) | Meta-azacyclic amino benzoic acid compounds and derivatives thereof | |
| BG102918A (en) | Biphenylsulphanomide inhibitors of the matrix metalloproteinase | |
| ES8604097A1 (es) | Procedimiento para preparar derivados del acido benzoico | |
| RU99127343A (ru) | Пролекарственные формы ингибиторов рибонуклеотидредуктазы 3-ар и 3-амр | |
| PT99381A (pt) | Processo para a preparacao de novos derivados de 3-cicloalquil-propanamidas e de composicoes farmaceuticas que as contem | |
| SE8406141D0 (sv) | N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa | |
| ATE20732T1 (de) | Halogenierte proteaseinhibitoren. | |
| KR970707140A (ko) | 평활근 세포 증식 억제제(Smooth muscle cell proliferation inhibitors) | |
| NO961404L (no) | 4-indolylpiperazinyl-derivater | |
| MY129537A (en) | Amino acid ester containing azole antifungals | |
| IL109076A (en) | 2-SUBSTITUTED 4,5-DIHYDROIMIDAZOLO £1,2-a| QUINOXALIN-4-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EA200000205A1 (ru) | Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов | |
| ATE153500T1 (de) | Verfahren zur inhibierung der fibrose | |
| ATE56967T1 (de) | Amidderivate. | |
| CO5130024A1 (es) | Derivados de azabicicloheptano n-sustituidos. . | |
| WO1998034917A3 (en) | Synthesis of acyclic nucleoside derivatives | |
| ES8202554A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |